Search

Heating, ventilating and air conditioning systems in hospital operating theatres consume high amounts of energy, operate for long periods of time and provide high performance. For this reason, it is necessary to study their energy consumption and determine sustainable solutions that optimize their operation and improve their performance. In this paper, annual thermal energy consumption of a conventional operating theatre is evaluated. Potential energy savings is evaluated by maintaining an adequate indoor environmental quality for these rooms. In addition, how to minimize energy consumption depending on the air renewal flow rate used and installing a sensible heat recovery system was studied. Results show that energy demand of an operating room is reduced by 24.1% by recirculating 25% of air flow extracted from the room. Energy cost decreases 44.31% by increasing the recirculated air flow rate to 50% of the air flow extracted from the room.

Viruses are among the most infectious pathogens, responsible for the highest death toll around the world. Lack of effective clinical drugs for most viral diseases emphasizes the need for speedy and accurate diagnosis at early stages of infection to prevent rapid spread of the pathogens. Glycans are important molecules which are involved in different biological recognition processes, especially in the spread of infection by mediating virus interaction with endothelial cells. Thus, novel strategies based on nanotechnology have been developed for identifying and inhibiting viruses in a fast, selective, and precise way. The nanosized nature of nanomaterials and their exclusive optical, electronic, magnetic, and mechanical features can improve patient care through using sensors with minimal invasiveness and extreme sensitivity. This review provides an overview of the latest advances of functionalized glyconanomaterials, for rapid and selective biosensing detection of molecules as biomarkers or specific glycoproteins and as novel promising antiviral agents for different kinds of serious viruses, such as the Dengue virus, Ebola virus, influenza virus, human immunodeficiency virus (HIV), influenza virus, Zika virus, or coronavirus SARS-CoV-2 (COVID-19).